Back to catalog
GrowthModerate evidence

GHRP-6

Growth hormone releasing peptide that also strongly increases appetite — useful or limiting depending on the goal.

Half-life
Short
Administration
Subcutaneous or research oral analogs
Primary uses
GH release research · Appetite stimulation models

Mechanism

GHS-R1a agonism drives GH pulses and ghrelin-like hunger signaling.

  • GH release research
  • Appetite stimulation models

Dosing ranges

Educational ranges only — not medical advice. Confirm protocols with a qualified clinician.

Use caseTypical rangeFrequencyNotes
Research GH pulse100–300 mcg2–3× dailyAppetite effect is often dose-limiting

Clinical evidence

Moderate evidence
Endocrine Reviews (class literature) · 2001

Growth hormone-releasing peptides

Established GH secretagogue activity with distinct side-effect signatures by compound.

Cautions

  • Marked hunger is common
  • Cortisol/prolactin rises possible
  • Not ideal when appetite suppression is the goal

Provider comparison

Affiliate-style comparison cards for clinics, telehealth, and research suppliers. Verify licensing and product quality before purchasing.

Fountain Health
telehealth
4.7
From $249/mo

Licensed clinician consult + ongoing titration support

Compare offer
PeakRx Clinic
clinic
4.5
From $189/mo

In-person labs available in select metros

Compare offer
Research Supply Co.
research
4.1
Vial pricing

Research-only sourcing — not for human consumption labeling

View listing
Growth
Moderate evidence

CJC-1295

Growth hormone releasing hormone analog designed to elevate GH and IGF-1 with extended activity versus native GHRH.

GH axis supportView research →
Growth
Moderate evidence

Ipamorelin

Selective growth hormone secretagogue with a cleaner side-effect profile than earlier GHRPs in comparative research.

GH pulse supportView research →